|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，： | 1 |
| 2 | Estim&tion of urban trMfic conditions using an Autom&tic Vehicle Location (AVL) System显示文摘 | DqAcierno L C&reni A Monteila B | 2009 | European Journ&] of Operation&] Eese&rch2009，196，2： | 1 |
| 3 | Gemcitabine versus cisplatin,epirubicin, 5 - fluorouracil, gemcitabine in advanced pancreaticcancer: a phase III trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，： | 1 |
| 4 | Irradiation fields and doses in glioblastoma multiforme:are current stantdards adequate显示文摘 | Reni M Cozzarini C Panucci M G | 2001 | Tumori2001，87，2： | 1 |
| 5 | Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables显示文摘 | Reny JL Vuagnat A R ant C | 2002 | Crit Care Med2002，30，： | 1 |
| 6 | Diagnosis and follow-up ofinfections in intensive care patients : value of C-reactive proteincompared with other clinical and biological variables 显示文摘 | Reny JL Vuagnat A Ract C | 2002 | Crit CareMed2002，30，3： | 1 |
| 7 | The specific throm- boxane receptor antagonist S18886: pharmacokinetic and pharmacodynamic studies 显示文摘 | Gaussem P Reny JL Thalamas C | | J Thromb Haemost0，3，7： | 1 |
| 8 | The specific thromboxane receptor antagonist S18886, pharmacokinetic and pharmacodynamic studies 显示文摘 | Gaussem P Reny JL Thalamas C | 2005 | J Thromb Haemost2005，3，： | 1 |
| 9 | Irradiation fields and doses in glioblast-oma multiforme:are current standards adequate显示文摘 | Reni M Cozzarini C Panucci MG | | 0，，02： | 1 |
| 10 | Lipid peroxidation and survival in rats following cerebral post-ischemia reperfusion:effect of drugs with different molecular mechanisms显示文摘 | Di-Giacomo C Sorrenti V | 1994 | Bio Chem Mol Biol Int1994，33，2： | 1 |
| 11 | Diagnosis and follow - up of infections in intensive care patients : value of C - reactive protein compared with other clinical and biological variables 显示文摘 | Reny JL Vuagnat A Ract C | 2002 | Crit Care Med2002，30，3： | 1 |
| 12 | Diagnosis and follow-up of infeetions in intensive care patients: value of C-reactive protein compared with other clinical and biological variables显示文摘 | Reny JL Vuagnat A Ract C | 2002 | Crit Care Med2002，30，3： | 1 |
| 13 | Influence of the paraoxonase-1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events:a systematic review and meta-analysis显示文摘 | Reny JL Combescure C Daali Y | | 0，，07： | 1 |
| 14 | Heat shock protein following rat cerebral ischemia/ reperfusion episode : effect of ketamine 显示文摘 | Renis M Di Giacomo C Sorrenti V | 1994 | Biochem Mol Biol Int1994，33，： | 1 |
| 15 | Lipid pero-xidation and survival in rats following cerebral post-ischemia reperfusion: effect of drugs with different molecular mechanisims 显示文摘 | Renis M Di-Giacomo C Sorrenti V | 1994 | Bio chem Mol-Bi-Int1994，33，2： | 1 |
| 16 | Gemcitabine versus cisplatin,epirubicin,fluorouracil,and gemcitabine in advanced pancreatic cancer:a randomized controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | 2005 | Lancet Oncol2005，6，6： | 1 |
| 17 | Response of cell cycle/ stress- related protein expression and DNA damage upon treatment of CaCO3 ceils with anthocyanins显示文摘 | Renis M Calandra L Scifo C Tomasello B Cardile V Vanella L Bei R La F L Calvane F | 2008 | British Journal of Nutrition2008，100，1： | 1 |
| 18 | Gemcitabine versus cisplatin,epirubicin,fluorouracil,and gemcitabine in advanced pancreatic cancer:a randomized controlled multicentre phase Ⅲ trial显示文摘 | Reni M Cordio S Milandri C | | 0，，6： | 1 |
| 19 | Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects显示文摘 | Amadesi S Reni C Katare R | | 0，，14： | 1 |
| 20 | Air pollution and carotid arterial stiffness in children显示文摘 | IANNUZZI A VERGA M C RENIS M | 2010 | Cardiol Young2010，20，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员